Related references
Note: Only part of the references are listed.Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation
A. Fundytus et al.
CLINICAL ONCOLOGY (2022)
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
Freddie Bray et al.
LANCET ONCOLOGY (2022)
Strengthening cancer control in Africa gathers momentum
The Lancet Oncology
LANCET ONCOLOGY (2022)
Hope for Africa's New Public Health Order to fight cancer
Munyaradzi Makoni
LANCET ONCOLOGY (2022)
An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries
J. Connor Wells et al.
JAMA ONCOLOGY (2021)
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
Adam Fundytus et al.
LANCET ONCOLOGY (2021)
Has the Current Oncology Value Paradigm Forgotten Patients' Time? Too Little of a Good Thing
Adam Fundytus et al.
JAMA ONCOLOGY (2021)
Communication With Older Patients With Cancer Using Geriatric Assessment A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program
Supriya G. Mohile et al.
JAMA ONCOLOGY (2020)
Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review
Clark DuMontier et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients - A systematic review
Marije E. Hamaker et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Look beyond technology in cancer care
Richard Sullivan et al.
NATURE (2017)
Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries
Merel Kimman et al.
BMC MEDICINE (2015)
The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people
T. Kalsi et al.
BRITISH JOURNAL OF CANCER (2015)
Anemia and Functional Disability in Older Adults With Cancer
Cynthia Owusu et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Predicting Life Expectancy in Patients With Metastatic Cancer Receiving Palliative Radiotherapy: The TEACHH Model
Monica S. Krishnan et al.
CANCER (2014)
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
Daniel Y. C. Heng et al.
LANCET ONCOLOGY (2013)
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
Martine Extermann et al.
CANCER (2012)
Embracing the Complexity of Comorbidity
Arti Hurria
JOURNAL OF CLINICAL ONCOLOGY (2011)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
External Validation of an Index to Predict Up to 9-Year Mortality of Community-Dwelling Adults Aged 65 and Older
Mara A. Schonberg et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Development and validation of a prognostic index for 4-year mortality in older adults
SJ Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization
LC Walter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Cancer screening in elderly patients - A framework for individualized decision making
LC Walter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
